BNP/CALL/MERCK & CO./100/0.1/20.12.24 | Market Closed - Deutsche Boerse AG 20:50:24 04/07/2024 BST | ||
| 2.57 EUR | -1.91% |
|
| Current month | -5.86% | ||
| 1 month | -11.07% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 04/07/24 | 2.57 | -1.91% |
| 03/07/24 | 2.62 | -7.42% |
| 02/07/24 | 2.83 | -1.74% |
| 01/07/24 | 2.88 | +5.49% |
| 28/06/24 | 2.73 | -9.60% |
Delayed Quote Deutsche Boerse AG
Last update July 04, 2024 at 08:50 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
BNP Paribas
|
| WKN | PE89AD |
| ISIN | DE000PE89AD2 |
| Date issued | 16/02/2023 |
| Strike | 100 $ |
| Maturity | 20/12/2024 (169 Days) |
| Parity | 10 : 1 |
| Emission price | 1.84 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.45 € |
|---|---|
| Lowest since issue | 0.93 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
125.8
USD
Average target price
142.7
USD
Spread / Average Target
+13.37%
- Stock Market
- Warrants
- Warrant
